Tech Company Financing Transactions
C2N Funding Round
C2N secured a $7 million financing round on 9/26/2024. Investors included Alzheimer's Drug Discovery Foundation and private investors.
Transaction Overview
Company Name
Announced On
9/26/2024
Transaction Type
Venture Equity
Amount
$7,025,000
Round
Undisclosed
Investors
Alzheimer's Drug Discovery Foundation (Lead Investor)
Proceeds Purpose
The company intends to use the funds to develop its biomarkers and novel diagnostic technologies.
Company Information
Company Status
Private & Independent
Industry
Real Estate
Mailing Address
4340 Duncan Avenue
St. Louis, MO 63110
USA
St. Louis, MO 63110
USA
Phone
Website
Email Address
Overview
C2N is a specialty diagnostics company providing exceptional laboratory services and products in the field of brain health. C2N's high-resolution mass spectrometry-based biomarker products and services are used for: clinical decision-making to improve patient care, including diagnosis and treatment monitoring; maximizing the quality and efficiency of clinical trials that test novel treatments for neurodegeneration; and providing innovative tools to help healthcare researchers better understand novel mechanisms of disease, identify new treatment targets, and conduct important epidemiological studies to improve global public health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joel Braunstein
Chief Medical Officer
Justine Coppinger
Co-Founder
Ilana Fogelman
Controller
Rachel Resnick
Vice President
Sheena Aurora
Vice President
Daniel Connell
Vice President
John Contois
Vice President
Chris Rathermel
VP - Customer Service
Brianne Peters
VP - Finance
Tim Reilly
VP - General Counsel
Micah Onixt
VP - Human Resources
Patricia DeSimone
VP - Marketing
Joni Henderson
VP - Operations
Ozgur Sensoy
VP - R & D
Matthew Meyer
VP - R & D
Philip Verghese
VP - R & D
Tim West
VP - Regulatory Affairs
Catherine Regni
Browse more venture capital transactions:
Prev: 9/26/2024: Mendaera venture capital transaction
Next: 9/27/2024: Cytix venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs